Why we exist
Who we are
Governance
Support CEPI
Calls for Proposals
Our portfolio
Platform Technology
Priority diseases
Vaccine scienceClear
To date, CEPI has established multiple partnership agreements, reflecting a potential investment of over $270 million. Through these collaborations, we're supporting the development of a wide range of vaccine candidates.
We also have number of additional partnerships under negotiation. These partnership agreements represent the start of CEPI’s product development portfolio. See below current details of our vaccine portfolio.
)
)
{{ d['description'] }}
